Current Research Grant Recipients

Funded Researchers

2019-2020 Funding Cycle - Current Research Grant Recipients

To download a PDF with the lay abstract for each research grant recipient, click here.

Daichi Inoue, M.D., Ph.D.

Daichi Inoue, MD, PhD – IBRI (Institute of Biomedical Research and Innovation)
Understanding the role of ZRSR2 mutations in myeloid malignancies

Rui Lu, Ph.D.

Rui Lu, PhD – University of Alabama
A Novel Stemness Program with Epigenetic Dysregulation in Acute Myeloid Leukemia


Raffaella Di Micco, PhD Ospedale San Raffaele
Targeting of Epigenetic Drivers of Immune Evasion in Acute Myeloid Leukemia Relapses After Allogeneic HSCT

Christopher Ott, PhD-2

Christopher Ott, PhD – Massachusetts General Hospital
Deciphering mechanisms of PAX5 addiction in lymphoma

Steven M. Chan, M.D., Ph.D.

Steven M. Chan, MD, PhD – Princess Margaret Cancer Center
Repurposing Metformin to Prevent Blood Cancers and Cardiovascular Diseases Associated with TET2
Mutation-Driven Clonal Hematopoiesis

Hamza Celik, Ph.D.

Hamza Celik, PhD – Washington University School of Medicine
Generation of a faithful patient-derived xenograft model of myelofibrosis for pre-clinical studies

Irum Khan, M.D.

Irum Khan, MD –University of Illinois at Chicago
Targeting FOXM1 to improve treatment responses in AML

Mario A. Blanco, Ph.D.

M. Andres Blanco, PhD – University of Pennsylvania
Dual targeting of LSD1 and KAT6A to induce therapeutic differentiation in AML

Capucine Van Rechem, Ph.D.

Capucine Van Rechem, PhD – Stanford University
Identify New Functions for PRMT5 in B-Cell Lymphoma to Unravel Therapeutic Strategies

Stephanie O. Berg, D.O.

Stephanie O. Berg, DO – Cardinal Bernardin Cancer Center, Loyola University Medical Center
Germline Mutations Predispose to Familial Myeloproliferative Neoplasms

Michael Milyavsky, Ph.D.

Michael Milyavsky, PhD – Tel Aviv University
Harnessing stemness reporter to identify and target critical dependency genes in human Leukemia Stem Cells

Yongsoo Kim Ph.D_

Yongsoo Kim, Ph.D. - VU University in Amsterdam, The Netherlands
A Computational Framework to Model Cellular Interplays in the Tumor Microenvironment of B Cell Lymphoma